5 Am Venture Management, LLC Portfolio Holdings

5 Am Venture Management, LLC

  • $251 Million
  • Q3 2024

5 Am Venture Management, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $251 Million distributed in 28 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Entrada Therapeutics, Inc. with a value of $70.5M, Tyra Biosciences, Inc. with a value of $22.1M, Centessa Pharmaceuticals PLC with a value of $20.5M, Celldex Therapeutics, Inc. with a value of $16.9M, and Viridian Therapeutics, Inc.\De with a value of $16.8M.

Examining the 13F form we can see an increase of $37.2M in the current position value, from $214M to 251M.

5 Am Venture Management, LLC is based out at San Francisco, CA

Below you can find more details about 5 Am Venture Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $251 Million
Healthcare: $251 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$562M
$70.5 Million 28.09% of portfolio
4,408,379
Q4 2021 New
$666M
$22.1 Million 8.8% of portfolio
939,298
Q1 2024 Added 69.25%
$1.58B
$20.5 Million 8.19% of portfolio
1,285,000
Q3 2024 Added 3.21%
$1.23B
$16.9 Million 6.73% of portfolio
497,270
Q4 2023 Added 60.27%
$789M
$16.8 Million 6.68% of portfolio
736,595
Q1 2024 Added 25.57%
$3.95B
$15 Million 5.99% of portfolio
237,560
Q1 2024 Reduced 59.39%
$692M
$14.8 Million 5.89% of portfolio
797,600
Q4 2023 Added 35.74%
$322M
$14.8 Million 5.88% of portfolio
5,405,404
Q2 2024 New
$1.82B
$14.2 Million 5.67% of portfolio
282,313
Q1 2024 Reduced 6.71%
$249M
$8.66 Million 3.45% of portfolio
476,200
Q1 2024 New
$305M
$8.39 Million 3.34% of portfolio
1,050,000
Q3 2024 Added 2,000.0%
$597M
$6.07 Million 2.42% of portfolio
561,854
Q3 2024 Reduced 28.92%
$95.9M
$5.47 Million 2.18% of portfolio
1,200,647
Q1 2023 Reduced 56.1%
$29.3M
$4.45 Million 1.77% of portfolio
6,361,723
Q4 2021 Reduced 4.94%
$31.8M
$4.25 Million 1.69% of portfolio
3,630,724
Q1 2023 Reduced 2.68%
$570M
$3.83 Million 1.53% of portfolio
572,665
Q1 2024 Added 41.61%
$178M
$1.8 Million 0.72% of portfolio
490,000
Q2 2023 New
Praxis Precision Medicines I
-
$0 0.0% of portfolio
-
Q1 2024 New
Anaptysbio Inc
-
$0 0.0% of portfolio
-
Q4 2022 New
Artiva Biotherapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Biohaven LTD
-
$0 0.0% of portfolio
-
Q3 2024 Added 1.92%
Cidara Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2024 New
Tectonic Therapeutic Inc
-
$0 0.0% of portfolio
-
Q2 2024 New
Skye Bioscience Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 2.62%
Dianthus Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 0.11%
Enliven Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 32.89%
Adverum Biotechnologies Inc
-
$0 0.0% of portfolio
-
Q1 2024 New

Summary

  • Portfolio
  • No. of Stocks 28
  • Current Value $251 Million
  • Prior Value $214 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 1 stocks
  • Additional Purchases 3 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 4 stocks
Track This Portfolio

Track 5 Am Venture Management, LLC Portfolio

Follow 5 Am Venture Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 5 Am Venture Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 5 Am Venture Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email